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Plant materials with antioxidant and skin anti-aging properties have been widely
used in cosmetic products for many years. Among them Camellia sinensis (L.) (green tea)
extract is known for its biological and pharmacological activities attributed mainly to
green tea catechins, which are polyphenolic compounds present in unfermented dried
leaves of C. sinensis (1, 2). A short heating procedure of green tea leaves led to inactiva-
tion of polyphenol oxidase, thereby preserving the antioxidant activities of polyphenols.
The total content of polyphenols in tea leaves varies from approximately 20 to 40 %, de-
pending on the subspecies of the plant and geographic location (3). The four major poly-
phenolic catechins present in green tea leaves are (2)-epicatechin (EC), epigallocatechin
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(EGC), (2)-epicatechin-3-gallate and epigallocatechin-3-gallate (EGCG). EGCG is the
most abundant and active polyphenol in green tea (3, 4).
An early study had already proved certain effects of a cream containing green tea
extract on the viscoelastic properties of the skin (5). In another study, a 60-day treatment
of green tea extract showed anti-wrinkle efficacy in healthy subjects and significant im-
provements have been observed on skin roughness, scaliness and wrinkling (2). Studies
on an in vitro model of human skin fibroblasts showed the protective effect of green tea
extract from toxic reactive oxygen species (6). In addition to its anti-oxidative and anti-
-ageing potentials, green tea may exert other therapeutic activities such as anti-cancer,
anti-inflammatory, anti-microbial, and anti-acne activities (1, 3, 7).
Topical in vivo applications of rose oil from the petals of Rosa damascena (Miller)
have been reported to improve skin barrier function and promote keratinocyte differen-
tiation (8). Furthermore, antioxidant and antimicrobial activities of rose oil were obser-
ved (9–11).
Antioxidants are introduced as primary ingredients especially into daytime cosme-
tics to scavenge free radicals produced by ultraviolet light (UV) and environmental pol-
lutants, which are involved in skin ageing processes (11). Green tea is apparently capa-
ble of providing skin protection against sun damage by quenching the skin with free
radicals (12–14). Human skin penetration and retention of EGCG from green tea extracts
has been found sufficient to exert positive effects on the skin (15).
In case of pharmaceutical forms, emulgels are emulsions that are gelled by mixing
with a gelling agent; they possess advantages of both emulsions and gels (16). Briefly,
ease of spreadability, convenience of viscosity and appearance and emollient effect can
be summarized as advantages of emulgels.
The objective of the present work is to design an emulgel formulation that includes
green tea leave extracts and rose essential oil because of the above mentioned effects of
these natural ingredients. For this purpose, emulgel formulations in pre-formulation
studies were evaluated in terms of pH and viscosity. Organoleptic controls and micro-
scopic analyses were performed before and after a stability period of 6 months. Accord-
ing to the results, the most stable formulation (F9A) containing 5 % rose oil and 20 %
green tea extract was chosen for in vivo experiments. Biophysical measurements were
used in order to evaluate the effect of the emulgel on skin hydration and transepidermal
water loss (TEWL) after a single and a 5-day-long period of multiple applications.
EXPERIMENTAL
Materials
Carbopol 1342 and Carbopol 934 were provided by BF Goodrich, Belgium. Glyceryl
monostearate, methylparaben, and propylparaben were purchased from Sigma-Aldrich,
USA. Cetostearyl alcohol, liquid paraffin, glycerine and triethanolamine were obtained
from Merck, Germany. Dimethicone was provided from Johnson and Johnson, Turkey.
Trademark products of rose oil (Shiffa Home, Turkey) and green tea leaves (Çaykur, Tur-
key) were purchased from a local market (Ankara, Turkey).
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Preparation of formulations
Emulgels were prepared in two steps, i.e., step I and step II. In step I, the gel phase
was prepared; in step II, the gel phase was combined with the oily phase in order to give
the final emulgel formulation. Step I and step II procedures were as follows:
Gel phase preparation
Briefly, the gel base was prepared by dispersing Carbopol 934 or Carbopol 1342 in
30 mL water using a magnetic stirrer in order to obtain a homogeneous gel base. Tri-
ethanolamine solution (5 %, m/m) was used to neutralize the pH and air bubbles were
removed using an ultrasonic water bath (Ultrasonic LC 30, Germany) for 1 h. The Carbo-
pol 934 gel phase was featured in formulations F1–F4 whereas Carbopol 1342 was fea-
tured in F5–F10. The codes and ingredients of formulations F1–F10 are given in Table I.
Emulgel preparation
Oil and water phases (Table I) were heated separately to 65 °C using a thermostatic
water bath (Heraeus, Germany) and then mixed by stirring on a magnetic stirrer (250
rpm) (Osaka, Japan). After an emulsion was formed, the gel phase was added under
continuous stirring. At that stage, an ultrasonic homogenizer (70 W, Bandelin Sanopuls
HD 2070, Germany) was used for formulations F9B and F10B as a second preparation
method.
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Table I. Content of the formulations (%, m/m)












1 1 1 1 1 1 1 1 1 1.5
Cetostearyl alcohol 3.5 3.5 3.5 3.5 3.5 3.5 3.5 3.5 3.5 4
Liquid paraffin 12 12 12 12 12 8 12 8 12 8
Dimeticone 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 4
Rose oil – – – – – 5 – 5 5 5







Methyl paraben 0.25 0.25 0.25 0.25 0.25 0.25 0.25 0.25 0.25 0.25
Glycerine 3 3 3 3 3 3 3 3 3 3
Carbopol 934 0.3 0.2 0.2 0.2 – – – – – –
Carbopol 1342 – – – – 0.3 0.3 0.3 0.3 0.3 0.3
Triethanolamine 0.18 0.18 – – 0.3 0.3 0.3 0.3 0.3 0.3
Green tea extract (mL) – – – 20 – – 20 20 20 20
Purified water (q.s.) 100 100 100 100 100 100 100 100 100 100
a F5 was used as Base Cream in studies in vivo.
In formulations F4 and F7–F10, green tea extract (20 g) produced from green tea lea-
ves (20 %, m/m) by a simple decoction method were added to the water phase of the
emulsion (17). In formulations F6 and F8–F10, 5 % rose oil was added to the final emul-
gel when its temperature decreased to 30 °C.
Characterization of emulgels
Emulgels were characterized by performing organoleptic controls, pH, viscosity
and microscopic analysis after the preparation and during the stability period.
Organoleptic controls
Organoleptic controls involving oily feel, spreadability, stickiness and ease of ab-
sorption were evaluated as 0 (unavailable), + (moderate), ++ (good), +++ (best). In addi-
tion, water dilution characteristics, homogeneity, odor and color of the formulations
were evaluated.
pH measurements
The pH measurements were done using a pH-meter (Inolab WTW Series pH 720,
Germany) at room temperature (24 ± 1 °C) after 24 hours and six months after prepara-
tion. Samples were prepared by dilution of 1 gram of emulgel to 10 mL with purified
water before the experiment. Measurements were taken in triplicates.
Viscosity measurements
Viscosity measurements and flow characteristics of the formulations were evaluated
using a rotational viscometer (Brookfield DVII, TF spindle, 25 ± 1 °C). Measurements
were taken in triplicates.
Microscopic analyses
Microscopic analyses were done using an optical microscope with 10× magnifica-
tion (Leica DM 400, Germany). Samples were carefully diluted 1:1 with purified water, if
dilution was required.
Stability tests
Formulations F1–F8 were stored in a cabin (Nüve ID 501, Turkey) of 25 ± 1 °C tem-
perature and 50 ± 5 % relative humidity for 6 months. Viscosity and microscopic chan-
ges were examined periodically.
Accelerated stability tests were performed to determine the stability of formulations
F9A, F9B, F10A and F10B under accelerated gravitational conditions as stated below
(18–20):
Freeze-thaw (F/T) cycling. – In the first cycle, formulations were kept at +4 °C in 25
mL glass bottles for 24 h and then thawed at 25 °C for 24 h. In the second cycle, samples
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kept at +4 °C for another 24 h were thawed at 40 °C for 1.5 h. Afterwards, samples were
equilibrated under room conditions for 1 h before viscosity measurements and micro-
scopic analyses were done. Control measurements were performed on samples kept at
25 °C. All formulations featured in freeze-thaw cycling stability were evaluated after 5 h
of centrifugation of 1500 g in terms of viscosity and microscopically.
Centrifugation method. – Centrifugation test was performed at 1500 g (~3750 rpm) in
a 10 mL tube using a laboratory centrifuge (Hettich Rotofix II, UK) at room temperature
(25 ± 1 °C). Inspection was done for possible phase separation after 15, 30, 60 minutes
and 5 hours (19).
In vivo studies
The in vivo studies were carried out in an examination room under constant envi-
ronmental conditions of 40 ± 5 % relative humidity and 21 ± 1 °C. Ten female volunteers,
of 24 to 39 years of age, were selected and signed the Terms of Informed Consent after
being informed about the objectives and research methods. Measurements were perfor-
med in accordance with the guidelines of the Standardization Group of the European
Society of Contact Dermatitis (21).
Single application. – Emulgel formulation F9A and the Base Cream (formulation F5
was chosen as base; Table I) were applied non-occlusively to the volar side of the fore-
arm of volunteers (10 female volunteers aged from 24–39 years). Skin water content and
TEWL were determined with a Corneometer and Tewameter (Courage & Khazaka elec-
tronic GmbH, Cologne, Germany), respectively. A single dose corresponding to 500.0 mg
of each formulation was applied to the defined test area partitioned into two test fields
using a self-adhesive tape (30 × 3 cm). After 15 minutes, the formulation that was still on
the skin was gently wiped off. The stratum corneum water content and skin barrier func-
tion were evaluated by biophysical measurements before application (baseline values)
and 15, 30, 60, 120, 180 and 240 minutes after removal of the formulation.
Multiple applications. – Five volunteers (24–39 years old) were asked to apply the
emulgel formulation F9A and the Base Cream twice daily over 5 days. At the end of the
treatment period, their skin water content and transepidermal water loss (TEWL) were
measured with the skin capacitance meter Corneometer CM 825 (Courage & Khazaka)
and Tewameter TM 210 (Courage&Khazaka), respectively.
The stratum corneum moisture content was determined with a non-invasive techni-
que using the Corneometer. Five individual measurements were carried out for each for-
mulation at any time point and the mean of the measured hydration values was calcu-
lated. Changes in skin hydration were detected as Corneometer units. The rate of TEWL,
as an indicator of skin barrier integrity, was determined using the Tewameter with a
measuring time of 1 min for each formulation at any time point. The value with the low-
est standard deviation was taken for comparison of the formulations. Before measure-
ments were taken, the participants were acclimatized for at least 30 minutes in the exam-
ination room under constant environmental conditions mentioned above. Volunteers
were requested not to use moisturizers, body lotions, soaps or occlusive cosmetic prepa-
rations on the tested skin areas 12 h prior to the in vivo study.
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RESULTS AND DISCUSSION
Results of the organoleptic evaluation of emulgel formulations F1–F10 are presen-
ted in Table II. Green tea extract gave a slightly green color to the formulations. F9B and
F10B, formulations produced by the sonication process, had opaque-greenly color in
their final form. Emulgel F5 showed the best spreadability and homogeneity among the
first five formulations and therefore this formulation was chosen as the vehicle (Base
Cream) for green tea extract and rose oil for further experiments. Emulgel formulations
F6–F10 derived from F5 showed good spreadability and homogeneity characteristics af-
ter being loaded with green tea extract and/or rose oil.
According to the results of pH analysis presented in Table III, when the gel was not
neutralized during preparation (F3 and F4), the finished emulgel product had also a
lower pH value (5.91 ± 0.025 and 6.62 ± 0.055, respectively) compared to that of emulgel
formulations F1 and F2 based on Carbopol 934.
Emulgel formulations F5–F10 were prepared with a neutralized gel phase based on
Carbopol 1342. After the addition of the oil phase, the pH of emulgel formulations was
in the range of 5.91 ± 0.025 and 7.35 ± 0.030. The pH value declined at the end of 6
months with some variations and ranged from 5.30 ± 0.03 to 6.75 ± 0.09, which is consid-
ered acceptable for avoiding the risk of skin irritation. The oxidation process and the for-
mation of oxidation products in the oil phase might be the reason for the slight reduc-
tion in pH values.
Neutralizing the gel phase before adding the emulsion phase was not necessary
only for appropriate pH, but also for achieving maximum viscosity in the final emulgel
formulation. In our study, emulgel F5 showed the highest viscosity among the first five
formulations. At the end of 6 months of storage, the decrease in viscosity of formula-
tions F6 and F8 was probably associated with the presence of rose oil in the formulation
(Fig. 1a). Increase in viscosity followed the order F4 > F1 > F5 > F3 > F2 = F7. As shown
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Table II. Organoleptic controls at the end of 24 hoursa
Control F1 F2 F3 F4 F5 F6 F7 F8 F9A F9B F10A F10B
Oily feelb 0 0 0 0 0 0 0 0 0 0 0 0
Spreadability ++ ++ ++ ++ +++ +++ +++ +++ +++ +++ +++ +++
Ease of absorption ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ ++
Water dilution ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ ++
Stickiness + + + + ++ ++ ++ ++ ++ ++ ++ ++
Homogeneity 0 + + 0 ++ ++ ++ +++ +++ +++ +++ +++
Odor + + + + + + + + + + + +
Colorc C W W SG W W SG SG SG OSG SG OSG
a 0 (unavailable), + (moderate), ++ (good), +++ (best)
b All the formulations gave an oily feel the first moment after application but after a few seconds this feeling
changed to a non-oily feel.
c C – Cream, W – White, SG – Slightly green, OSG – Opac and slightly green
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Table III. pH of the prepared formulations at different time intervals
Formulation Gel phase (24 h) Emulgel (24 h) Emulgel (6 months)
F1 6.60 ± 0.050 7.18 ± 0.035 6.25 ± 0.030
F2 5.95 ± 0.060 6.75 ± 0.040 6.30 ± 0.025
F3 3.50 ± 0.031 5.91 ± 0.025 5.30 ± 0.025
F4 3.50 ± 0.045 6.62 ± 0.055 5.83 ± 0.060
F5 6.20 ± 0.068 7.18 ± 0.075 6.75 ± 0.085
F6 6.20 ± 0.025 7.35 ± 0.030 6.54 ± 0.025
F7 6.20 ± 0.030 7.24 ± 0.060 6.29 ± 0.015
F8 6.03 ± 0.082 6.87 ± 0.045 5.86 ± 0.065
F9A 6.06 ± 0.029 6.91 ± 0.025 5.98 ± 0.030
F9B 6.04 ± 0.040 6.77 ± 0.070 6.04 ± 0.075
F10A 6.04 ± 0.061 7.06 ± 0.032 6.14 ± 0.035
F10B 6.01 ± 0.035 7.11 ± 0.065 6.30 ± 0.050
Fig. 1. a) Viscosity of F1–F8 before and after 6 months of storage, b) viscosity of F9A, F9B, F10A and
F10B obtained 24 hours after preparation and after the freeze-thaw cycle, respectively (20 rpm).
in Fig. 1b, after freeze thaw studies the viscosity changes in formulations F9B and F10B,
produced by ultrasonication, were higher than in formulations F9A and F10A prepared
using magnetic stirring. Greater impact of freeze thaw cycling on F9B and F10B could be
dependent on the tendency of the two formulations prepared by the ultrasonication me-
thod towards changes in interface stability.
The final acceptance of an emulsion depends on the stability, appearance and func-
tionality of the product (20). In our study, a long-term stability test was carried out at 25
± 1 °C and 50 ± 5 % relative humidity on formulations F1–F8, while formulations F9A,
F9B, F10A and F10B were subjected to accelerated stability tests. Viscosity measurements
and optical microscopic analyses were conducted in order to examine any changes in
homogeneity and phase separation. Optical microscopy was used to observe and evalu-
ate the size of droplets individually. Fig. 2 shows the photomicrographs of emulgels F1,
F5 and F8 after 24 h and 6 months. As can be seen from these micrographs, all of the
samples showed some degree of droplet coalescence over the entire 6-month period.
To evaluate the effect of the increased amount of oil phase on emulgel homogeneity,
microscopic analyses were carried out on formulations F9–F10 before and after stability
testing (Fig. 3). Ultrasonication process resulted in smaller globules and more homoge-
neous emulgels were obtained with formulations F9B and F10B. The micrographs before
and after accelerated stability tests showed that homogeneity of the formulations did
not change and the micrographs can be interpreted as a prediction of long-term stability
for emulgel formulations F9A, F9B, F10A and F10B.
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Fig. 2. Optical microscopy of F1, F5 and F8 (×10 magnification) after 24 h and 6 months, a) F1; 24 h,
b) F5; 24 h, c) F8; 24 h, d) F1; 6 months, e) F5; 6 months, f) F8; 6 months.
It has been reported that a centrifugation process at 1500 g (3750 rpm) for 5 h can be
used in order to interpret long-term stability of an emulsion (11). Emulgel formulations
F9A, F9B, F10A and F10B maintained their consistency and homogeneity after 1 and 5 h
of centrifugation and no phase separation was detected. The emulgel formulation F9A,
showing the most promising organoleptic characteristics, spreadability, viscosity and
stability, was chosen for in vivo studies. Formulation F5 was used as the Base Cream in
in vivo studies.
Noninvasive skin biophysical techniques allowing evaluation of skin care products
have found place in cosmetology and dermatology, under actual conditions of use. Hy-
dration and skin barrier function measurements are among the most widely used tech-
niques (22–23). Determination of the hydration state of stratum corneum is generally
based on electrical measurements on the skin surface. Corneometer is a well-known and
efficient instrument for measuring the hydration of stratum corneum based on the capaci-
tance method (22–24). Water has a crucial role in respect to the normal function of the
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Fig. 3. Optical microscopy of F9A, F9B, F10A and F10B before and after accelerated stability tests
(x10 magnification).
epidermal barrier and mechanical properties of skin. Water content of stratum corneum is
therefore of particular interest in most cosmetic and dermatologic applications (23, 25).
Results of the skin water content measurements after a single application of emul-
gel formulation F9A and Base Cream averaged over 10 volunteers are represented in Fig.
4a. Maximum value was achieved within 30 min after application, exhibiting a 1.4 fold
increase (p < 0.05). Skin water content reached constant values after 180 min with the
emulgel F9A formulation and remained higher than the treatment with Base Cream. The
presence of rose oil and green tea extract may have had a positive effect on the increase
in skin water content. Green tea extract has been reported to protect against UV irradia-
tion induced photo-aging, photo-immunosuppression, cutaneous erythema, thickening
of the epidermis and to prevent oxidative stress and DNA damage (26). Rose oil may in-
teract synergistically with the oily ingredient of the emulgel and help form an effective
protective film on the skin surface.
Passive diffusion of water from hydrated layers of the dermis and epidermis to-
ward the superficial stratum corneum layer is defined as TEWL. TEWL measurements
can provide a good insight into the efficacy of a new product. Measurement of TEWL is
one of the most widely used biophysical methods because it correlates directly with the
skin barrier dysfunction and has applications in cosmetology, pharmaceutical, clinical,
toxicological, and various other studies (25, 27–29). Tewameter is a well-known device
capable of measuring TEWL accurately by using the open-chamber method (28).
Results of TEWL measurements after a single application of emulgel F9A and Base
Cream averaged over 10 volunteers are given in Fig. 4b. 15 min after the application of
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Fig. 4. a) Skin water content measurement after a single application of Emulgel formulation F9A ()
and Base Cream () averaged over 10 volunteers, b) Skin barrier function measurement after a sin-
gle application of Emulgel formulation F9A and Base cream averaged over 10 volunteers.
both formulations, TEWL was increased (7.3 ± 1.2 and 7.4 ± 2.4 g h–1 m–2 for F9A and
Base Cream, respectively) compared to the baseline (5.6 ± 2.3 g h–1 m–2) due to evapora-
tion of the water contained in the formulation on contact with the skin surface. The ob-
served TEWL values after single applications of the two formulations were not signifi-
cantly different in comparison with the baseline.
Long-term application of emulgel F9A resulted in significantly higher skin water
content compared to that of untreated skin (p < 0.05). The average TEWL value mea-
sured after 5 days of emulgel F9A application was considerably lower compared to that
of the Base Cream and baseline (Fig. 5). The significant increase in skin humidity proves
that stratum corneum hydration depends both on the ability to bind and the ability to re-
tain water (30). As TEWL refers to the total amount of water loss through the skin, lower
TEWL values indicate an intact epidermal barrier function that correlates with the nor-
mal hydration state of the stratum corneum (25, 27).
CONCLUSIONS
Based on the results of our study, it can be concluded that the emulgel formulation
F9A, including green tea extract and rose oil, was ideal in terms of applicability and sta-
bility. It showed a significantly higher hydration effect on human skin by enhancing the
skin barrier function. Further investigations should be considered for enhancing the sta-
bility of green tea extract and rose oil in the formulation. In vivo studies should be per-
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Fig. 5. a) Skin water content, and b) TEWL values averaged over all 5 volunteers after 5 days of ap-
plication of Emulgel F9A and Base Cream.
formed under simulated dry or sub erythema UV exposure treatments in order to evalu-
ate the moisturizing and skin barrier protecting effects of this emulgel formulation more
accurately.
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